EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Administration of 4% tetrasodium EDTA lock solution and central venous catheter complications in high‐risk pediatric patients with intestinal failure: A retrospective cohort study

Thomas I Hirsch iD, Scott C Fligor iD, Savas T Tsikis iD, Paul D Mitchell, Angela DeVietro iD, Sarah Carbeau iD, Sarah Z Wang iD, Jennifer McClelland, Alexandra N Carey, Kathleen M Gura iD, Mark Puder iD

Journal of Parenteral and Enteral Nutrition · 2024

DOI: 10.1002/jpen.2644 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Parenteral and Enteral Nutrition, 2024. Verfasst von Thomas I Hirsch und 10 weiteren Autor:innen. Beteiligte Einrichtung: Vascular Biology Program, Department of Surgery, Boston Children's Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Edetic Acid, Central Venous Catheters, Catheter-Related Infections, Catheterization, Central Venous. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS, This project was supported by National Institutes of Health 5T32HL007734 (Scott C. Fligor and Thomas I. Hirsch) and 2T32DK007754-22 (Savas T. Tsikis), the Rich….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Selection of central venous catheter (CVC) lock solution impacts catheter mechanical complications and central line–associated bloodstream infections (CLABSIs) in pediatric patients with intestinal failure. Disadvantages of the current clinical standards, heparin and ethanol lock therapy (ELT), led to the discovery of new lock solutions. High‐risk pediatric patients with intestinal failure who lost access to ELT during a recent shortage were offered enrollment in a compassionate use trial with 4% tetrasodium EDTA (T‐EDTA), a lock solution with antimicrobial, antibiofilm, and antithrombotic properties.

Methods

We performed a descriptive cohort study including 14 high‐risk pediatric patients with intestinal failure receiving 4% T‐EDTA as a daily catheter lock solution. CVC complications were documented (repairs, occlusions, replacements, and CLABSIs). Complication rates on 4% T‐EDTA were compared with baseline rates, during which patients were receiving either heparin or ELT (designated as heparin/ELT).

Results

Patients initiated 4% T‐EDTA at the time they were enrolled in the compassionate use protocol. Use of 4% T‐EDTA resulted in a 50% reduction in CVC complications, compared with baseline rates on heparin/ELT (incidence rate ratio: 0.50; 95% CI, 0.25–1.004; P = 0.051).

Conclusion

In a compassionate use protocol for high‐risk pediatric patients with intestinal failure, the use of 4% T‐EDTA reduced composite catheter complications, including those leading to emergency department visits, hospital admissions, additional procedures, and mortality. This outcome suggests 4% T‐EDTA has benefits over currently available lock solutions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Edetic AcidCentral Venous CathetersCatheter-Related InfectionsCatheterization, Central VenousIntestinal FailureHumansRetrospective StudiesFemaleMaleChild, PreschoolInfantChildHeparinCompassionate Use TrialsCohort Studies

Stichwörter der Autor:innen

4% tetrasodium EDTAbacteremiaethanol/adverse effectsintestinal failurepediatrics

Substanzen

Edetic AcidHeparin

Autor:innen und Institutionen

  • Vascular Biology Program, Department of Surgery, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Harvard Medical School, Boston, Massachusetts, USA.
  • Biostatistics and Research Design Center, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Division of Gastroenterology, Hepatology, and Nutrition, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Department of Pharmacy, Boston Children's Hospital, Boston, Massachusetts, USA.

ORCID-Profile: Thomas I Hirsch, Scott C Fligor, Savas T Tsikis, Angela DeVietro, Sarah Carbeau, Sarah Z Wang, Kathleen M Gura, Mark Puder

Förderung

  • NIDDK NIH HHS
  • NHLBI NIH HHS
  • This project was supported by National Institutes of Health 5T32HL007734 (Scott C. Fligor and Thomas I. Hirsch) and 2T32DK007754-22 (Savas T. Tsikis), the Rich…

Zitieren

APA

Hirsch, T. I., Fligor, S. C., Tsikis, S. T., Mitchell, P. D., DeVietro, A., Carbeau, S., Wang, S. Z., McClelland, J., Carey, A. N., Gura, K. M., & Puder, M. (2024). Administration of 4% tetrasodium EDTA lock solution and central venous catheter complications in high‐risk pediatric patients with intestinal failure: A retrospective cohort study. Journal of Parenteral and Enteral Nutrition. https://doi.org/10.1002/jpen.2644

Vancouver

Hirsch TI, Fligor SC, Tsikis ST, Mitchell PD, DeVietro A, Carbeau S, et al. Administration of 4% tetrasodium EDTA lock solution and central venous catheter complications in high‐risk pediatric patients with intestinal failure: A retrospective cohort study. Journal of Parenteral and Enteral Nutrition. 2024. doi:10.1002/jpen.2644

BibTeX
@article{Hirsch2024,
  author = {Hirsch, Thomas I and Fligor, Scott C and Tsikis, Savas T and Mitchell, Paul D and DeVietro, Angela and Carbeau, Sarah and Wang, Sarah Z and McClelland, Jennifer and Carey, Alexandra N and Gura, Kathleen M and Puder, Mark},
  title = {Administration of 4% tetrasodium EDTA lock solution and central venous catheter complications in high‐risk pediatric patients with intestinal failure: A retrospective cohort study},
  journal = {Journal of Parenteral and Enteral Nutrition},
  year = {2024},
  doi = {10.1002/jpen.2644}
}
Kostenlos starten →